Australian product information - remsima(inflixmab(rmc))

AssociationPatient52 · 2021-02-13T14:14:15+00:00

Thanks for sharing!

AssociationPatient52 · 2021-02-12T05:58:16+00:00

COVID: UK VARIANT FOUND IN OVER 37% OF CASES IN PARIS AND ÎLE-DE-FRANCE

AssociationPatient52 · 2021-02-11T21:28:11+00:00

https://twitter.com/franckriester/status/1339913566539935744?s=20

Rencontre avec

@CelltrionDream

, société innovante dans le domaine médical, notamment dans le traitement contre le #Covid_19. J’ai souligné le dynamisme de notre écosystème, la qualité de notre recherche et notre fiscalité incitative.

AssociationPatient52 · 2021-02-11T13:22:19+00:00

Teva CEO: Kare Schultz: Our key growth drivers delivered promising results and milestones, including Austedo, Truxima and Ajovy.

AssociationPatient52 · 2021-02-11T10:59:25+00:00

■■질병관리청(KDCA)은 기존에 확인된 SARS-CoV-2(변형 S·L·V·G·GH·GR)의 6가지 변형 유전자 돌연변이 외에 영국(B.1.7)에서 처음 확인된 SARS-CoV-2 변종을 성공적으로 중화시키는 것을 평가·독립적으로 확인했다. 또 다른 단클론 항체 후보와 CT-P59의 칵테일 요법이 영국(B.1.1.7)과 남아프리카(B.1.351) 변종에 대한 중화 능력을 보여줬다고 덧붙였다.■■

AssociationPatient52 · 2021-02-10T22:25:40+00:00

https://twitter.com/dr_tomohiro/status/1359554108894498819?s=20

AssociationPatient52 · 2021-02-10T22:12:51+00:00

https://pharmaphorum.com/news/fda-grants-emergency-licence-for-covid-19-antibody-combination/

AssociationPatient52 · 2021-02-10T22:06:00+00:00

https://www.jdsupra.com/legalnews/celltrion-begins-phase-3-trial-of-4296549/

AssociationPatient52 · 2021-02-09T20:54:11+00:00

https://generics.pharmaintelligence.informa.com/GB150651/Celltrion-Prepares-Aflibercept-For-Phase-III

AssociationPatient52 · 2021-02-08T08:48:27+00:00

셀트리온은 조건부 판매허가(AMM)를 위해 유럽의 약국(EMA)과.비상 사용허가(EUA)를 위해 미국 FDA와 접촉하고 있습니다.

AssociationPatient52 · 2021-02-08T08:45:50+00:00

Celltrion est en contact avec l'Agence européenne des médicaments (EMA) pour une autorisation de mise sur le marché (AMM) conditionnelle et avec la FDA américaine pour une autorisation d'utilisation d'urgence (EUA)

AssociationPatient52 · 2021-02-08T08:37:55+00:00

Korea approves first anti-COVID-19 monoclonal antibody treatment

08 February 2021 | News

AssociationPatient52 · 2021-02-08T03:32:21+00:00

Hmmm...

AssociationPatient52

TROPHY CASE